kabutan

Kubota Pharma, Last Fiscal Year's Net Income Loss Narrows, Current period performance is undisclosed.

Fri Feb 13, 2026 3:30 pm JST Earnings

4596 Kubota Pharmaceutical Holdings Co., Ltd. 【IFRS】

Earnings Report

Kubota Pharmaceutical Holdings Co., Ltd. <4596> [TSE Growth] announced its financial results (based on IFRS) after the market closed on February 13th (15:30). The consolidated net loss for the fiscal year ended December 2025 was loss of 0.67 billion yen, a reduction in the deficit compared to loss of 1.33 billion yen in the previous term. This marks the eleventh consecutive term of losses. Furthermore, the company did not disclose the performance outlook for the fiscal year ending December 2026.

In the most recent three-month period, from October to December (4Q), the consolidated net loss improved to a deficit of 0.24 billion yen (compared to a loss of 0.33 billion yen in the same period last year). However, the operating profit/loss margin drastically worsened from -3900.0% in the same period last year to -8033.3%.

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2023 40 -1,504 -1,490 -1,490 -26.8 0 Feb 14, 2024 IFRS
Dec, 2024 27 -1,345 -1,333 -1,333 -23.7 0 Feb 14, 2025 IFRS
Dec, 2025 21 -895 -676 -676 -10.6 0 Feb 13, 2026 IFRS
YoY -22.2% +33.5% +49.3% +49.3% +55.2%

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2025 Guidance 21 -877 -659 -659 -11.7 0 Feb 10, 2026 IFRS
Dec, 2025 Results 21 -895 -676 -676 -10.6 0 Feb 13, 2026 IFRS
Revision Rate 0.0% -2.1% -2.6% -2.6% +9.4%

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jan - Jun, 2025 13 -450 -450 -450 -7.7 0 Aug 14, 2025 IFRS
Jan - Jun, 2026 Guidance ー ー ー ー － 0 Feb 13, 2026 IFRS
YoY － － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2024 27 -1,345 -1,333 -1,333 -23.7 0 Feb 14, 2025 IFRS
Dec, 2025 21 -895 -676 -676 -10.6 0 Feb 13, 2026 IFRS
Dec, 2026 Guidance ー ー ー ー － 0 Feb 13, 2026 IFRS
YoY － － － － －

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2024 10 -390 -333 -333 -5.9 -3,900.0 Feb 14, 2025 IFRS
Jan - Mar, 2025 7 -259 -259 -259 -4.5 -3,700.0 May 14, 2025 IFRS
Apr - Jun, 2025 6 -191 -191 -191 -3.3 -3,183.3 Aug 14, 2025 IFRS
Jul - Sep, 2025 5 -204 15 15 0.2 -4,080.0 Nov 14, 2025 IFRS
Oct - Dec, 2025 3 -241 -241 -241 -3.8 -8,033.3 Feb 13, 2026 IFRS
YoY -70.0% +38.2% +27.6% +27.6% +36.0%

Related Articles